Stitch showdown: which suture makes the best scar?

NCT ID NCT07582679

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial compares two types of suture material—polypropylene and polyglactin—for closing upper limb wounds. Researchers will assess scar quality and infection rates in 100 adults undergoing surgery. The goal is to determine which material leads to better cosmetic outcomes and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
suture material (polypropylene or polyglactin)
What this could lead to
If one suture material proves better, it could guide surgeons to choose the best option for upper limb wound closure, improving scar appearance and reducing infection risk.
What could go wrong
This is a small, early-stage trial with only 100 participants, so results may not apply to all patients or wound types. Differences between materials may be small or not clinically meaningful.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged ≥18 years * Patients undergoing any surgical procedure involving the upper limb * Procedures performed in either elective or emergency settings * Wounds suitable for primary subcuticular skin closure * Ability to provide informed consent Exclusion Criteria: * Heavily contaminated or infected wounds * Patients with uncontrolled diabetes mellitus, chronic steroid use, immunosuppression or peripheral vascular disease * Crush injuries and wounds with significant tissue loss * Known allergy to suture material * Delayed primary closure wounds

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Compare cosmetic outcomes of subcuticular skin closure using polypropylene and polyglactin are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shebin El Koum teaching Hospital

    RECRUITING

    Menoufia Governorate, 33511, Egypt